Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3281670, 10 pages
https://doi.org/10.1155/2017/3281670
Research Article

Diosmin Attenuates Methotrexate-Induced Hepatic, Renal, and Cardiac Injury: A Biochemical and Histopathological Study in Mice

1Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
2Department of Pharmacology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
3Faculty of Medicine, Ain Shams University, Cairo, Egypt
4Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia
5Department of Zoology and Entomology, College of Science, Helwan University, Cairo, Egypt

Correspondence should be addressed to Mohamed M. Abdel-Daim; ge.ude.zeus.tev@m.miadledba

Received 22 March 2017; Revised 8 June 2017; Accepted 12 June 2017; Published 27 July 2017

Academic Editor: Francisco J. Romero

Copyright © 2017 Mohamed M. Abdel-Daim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Jolivet, K. H. Cowan, G. A. Curt, N. J. Clendeninn, and B. A. Chabner, “The pharmacology and clinical use of methotrexate,” New England Journal of Medicine, vol. 309, no. 18, pp. 1094–1104, 1983. View at Publisher · View at Google Scholar
  2. J. A. M. Wessels, T. W. J. Huizinga, and H.-J. Guchelaar, “Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis,” Rheumatology, vol. 47, no. 3, pp. 249–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. M. Hersh, V. G. Wong, E. S. Henderson, and E. J. Freireich, “Hepatotoxic effects of methotrexate,” Cancer, vol. 19, no. 4, pp. 600–606, 1966. View at Google Scholar
  4. P. E. Kintzel, “Anticancer drug—induced kidney disorders,” Drug Safety, vol. 24, no. 1, pp. 19–38, 2001. View at Publisher · View at Google Scholar
  5. H. Tobias and R. Auerbach, “Hepatotoxicity of long-term methotrexate therapy for psoriasis,” Archives of Internal Medicine, vol. 132, no. 3, pp. 391–396, 1973. View at Google Scholar
  6. A. Perez-Verdia, F. Angulo, F. L. Hardwicke, and K. M. Nugent, “Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 25, no. 9, pp. 1271–1276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Neuman, R. G. Cameron, J. A. Haber, G. G. Katz, I. M. Malkiewicz, and N. H. Shear, “Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytotoxicity,” Clinical Biochemistry, vol. 32, no. 7, pp. 519–536, 1999. View at Google Scholar
  8. B. A. Kamen, P. A. Nylen, B. M. Camitta, and J. R. Bertino, “Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug,” British Journal of Haematology, vol. 49, no. 3, pp. 355–360, 1981. View at Google Scholar
  9. W. H. Vogel, R. Snyder, and M. P. Schulman, “The inhibition of dehydrogenases by folic acid and several of its analogs,” Biochemical and Biophysical Research Communications, vol. 10, pp. 97–101, 1963. View at Google Scholar
  10. K. Kurosawa, H. Shibata, N. Hayashi, N. Sato, T. Kamada, and K. Tagawa, “Kinetics of hydroperoxide degradation by NADP-glutathione system in mitochondria,” The Journal of Biochemistry, vol. 108, no. 1, pp. 9–16, 1990. View at Google Scholar
  11. J. W. Williams, J. F. Morrison, and R. G. Duggleby, “Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase,” Biochemistry, vol. 18, no. 12, pp. 2567–2573, 1979. View at Google Scholar
  12. M. Szymański, D. Młynarek, A. Szymański, and I. Matławska, “Simultaneous determination of diosmin and hesperidin in pharmaceuticals by RPLC using ionic liquids as mobile phase modifiers,” Iranian Journal of Pharmaceutical Research: IJPR, vol. 15, no. 1, p. 141, 2016. View at Google Scholar
  13. M. Tahir, M. U. Rehman, A. Lateef et al., “Diosmin protects against ethanol-induced hepatic injury via alleviation of inflammation and regulation of TNF-α and NF-κB activation,” Alcohol, vol. 47, no. 2, pp. 131–139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Srinivasan and L. Pari, “Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats,” Chemico-Biological Interactions, vol. 195, no. 1, pp. 43–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Tanaka, H. Makita, M. Ohnishi et al., “Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination,” Cancer Research, vol. 57, no. 2, pp. 246–252, 1997. View at Google Scholar
  16. S. Ahmed, N. Mundhe, M. Borgohain et al., “Diosmin modulates the NF-kB signal transduction pathways and downregulation of various oxidative stress markers in alloxan-induced diabetic nephropathy,” Inflammation, vol. 39, no. 5, pp. 1783–1797, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Senthamizhselvan, J. Manivannan, T. Silambarasan, and B. Raja, “Diosmin pretreatment improves cardiac function and suppresses oxidative stress in rat heart after ischemia/reperfusion,” European Journal of Pharmacology, vol. 736, pp. 131–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. S. S. Queenthy and B. John, “Diosmin exhibits anti-hyperlipidemic effects in isoproterenol induced myocardial infarcted rats,” European Journal of Pharmacology, vol. 718, no. 1–3, pp. 213–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Mukherjee, S. Ghosh, S. Choudhury et al., “Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-κB pathways,” The Journal of Nutritional Biochemistry, vol. 24, no. 12, pp. 2040–2050, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Imam, N. O. Al-Harbi, M. M. Al-Harbi et al., “Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice,” Pharmacological Research, vol. 102, pp. 1–11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Reitman and S. Frankel, “A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases,” American Journal of Clinical Pathology, vol. 28, no. 1, pp. 56–63, 1957. View at Google Scholar
  22. P. R. N. Kind and E. J. King, “Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine,” Journal of Clinical Pathology, vol. 7, no. 4, p. 322, 1954. View at Google Scholar
  23. K. Larsen, “Creatinine assay in the presence of protein with LKB 8600 reaction rate analyser,” Clinica Chimica Acta, vol. 38, no. 2, pp. 475-476, 1972. View at Google Scholar
  24. J. J. Coulombe and L. Favreau, “A new simple semimicro method for colorimetric determination of urea,” Clinical Chemistry, vol. 9, pp. 102–108, 1963. View at Google Scholar
  25. G. Szasz, J. Waldenström, and W. Gruber, “Creatine kinase in serum: 6. Inhibition by endogenous polyvalent cations, and effect of chelators on the activity and stability of some assay components,” Clinical Chemistry, vol. 25, no. 3, pp. 446–452, 1979. View at Google Scholar
  26. U. Würzburg, N. Hennrich, H. Lang, W. Prellwitz, D. Neumeier, and M. Knedel, “Determination of creatine kinase-MB in serum using inhibiting antibodies (author’s transl),” Klinische Wochenschrift, vol. 54, no. 8, pp. 357–360, 1976. View at Google Scholar
  27. S. R. Babson and A. L. Babson, “An improved amylase assay using dyed amylopectin,” Clinica Chimica Acta, vol. 44, no. 2, pp. 193–197, 1973. View at Google Scholar
  28. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar
  29. L. C. Green, D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum, “Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids,” Analytical Biochemistry, vol. 126, no. 1, pp. 131–138, 1982. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Beutler, O. Duron, and B. M. Kelly, “Improved method for the determination of blood glutathione,” The Journal of Laboratory and Clinical Medicine, vol. 61, pp. 882–888, 1963. View at Google Scholar
  31. M. Nishikimi, N. A. Rao, and K. Yagi, “The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen,” Biochemical and Biophysical Research Communications, vol. 46, no. 2, pp. 849–854, 1972. View at Google Scholar
  32. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Google Scholar
  33. W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione S-transferases the first enzymatic step in mercapturic acid formation,” Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130–7139, 1974. View at Google Scholar
  34. G. Zanetti, “Rabbit liver glutathione reductase. Purification and properties,” Archives of Biochemistry and Biophysics, vol. 198, no. 1, pp. 241–246, 1979. View at Google Scholar
  35. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Google Scholar
  36. J. Chladek, J. Martinkova, and L. Sispera, “An in vitro study on methotrexate hydroxylation in rat and human liver,” Physiological Research, vol. 46, no. 5, pp. 371–379, 1997. View at Google Scholar
  37. T. Çakır, A. Baştürk, C. Polat et al., “Does alfa lipoic acid prevent liver from methotrexate induced oxidative injury in rats?” Acta Cirurgica Brasileira, vol. 30, no. 4, pp. 247–252, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Hemeida and O. M. Mohafez, “Curcumin attenuates methotraxate-induced hepatic oxidative damage in rats,” Journal of the Egyptian National Cancer Institute, vol. 20, no. 2, pp. 141–148, 2008. View at Google Scholar
  39. A. Aslaner, T. Çakır, B. Çelik et al., “The protective effect of intraperitoneal medical ozone preconditioning and treatment on hepatotoxicity induced by methotrexate,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 8, pp. 13303–13309, 2015. View at Google Scholar
  40. H. B. Ulusoy, İ. Öztürk, and M. F. Sönmez, “Protective effect of propolis on methotrexate-induced kidney injury in the rat,” Renal Failure, vol. 38, no. 5, pp. 744–750, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Yuksel, R. Yuksel, M. Yagmurca et al., “Effects of quercetin on methotrexate-induced nephrotoxicity in rats,” Human & Experimental Toxicology, vol. 36, pp. 51–61, 2017. View at Publisher · View at Google Scholar
  42. A. K. Kiemer, T. Hartung, and A. M. Vollmar, “cGMP-mediated inhibition of TNF-α production by the atrial natriuretic peptide in murine macrophages,” The Journal of Immunology, vol. 165, no. 1, pp. 175–181, 2000. View at Google Scholar
  43. J. J. Navarro, F. F. Milena, C. Mora et al., “Tumor necrosis factor-α gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition,” Kidney International, vol. 68, pp. S98–S102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Jo, T.-H. Kim, D.-W. Seol et al., “Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand,” Nature Medicine, vol. 6, no. 5, pp. 564–567, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. M. B. Duran-Salgado and A. F. Rubio-Guerra, “Diabetic nephropathy and inflammation,” World Journal of Diabetes, vol. 5, no. 3, pp. 393–398, 2014. View at Publisher · View at Google Scholar
  46. J. F. Navarro-González and C. Mora-Fernández, “The role of inflammatory cytokines in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 433–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. U. Rehman, M. Tahir, A. Q. Khan et al., “Diosmin protects against trichloroethylene-induced renal injury in Wistar rats: plausible role of p53, Bax and caspases,” British Journal of Nutrition, vol. 110, no. 4, pp. 699–710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Zhou, V. S. Vaidya, R. P. Brown et al., “Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium,” Toxicological Sciences, vol. 101, no. 1, pp. 159–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. T. Ahmad, W. Arjumand, A. Seth et al., “Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways,” Toxicology, vol. 290, no. 1, pp. 69–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Silambarasan and B. Raja, “Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats,” European Journal of Pharmacology, vol. 679, no. 1–3, pp. 81–89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. Y.-J. Kim, M. Song, and J.-C. Ryu, “Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway,” Toxicology, vol. 256, no. 3, pp. 183–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Liu, X. Zhang, J. Zhang et al., “Diosmin protects against cerebral ischemia/reperfusion injury through activating JAK2/STAT3 signal pathway in mice,” Neuroscience, vol. 268, pp. 318–327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Tanaka, H. Makita, K. Kawabata et al., “Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination,” Carcinogenesis, vol. 18, no. 4, pp. 761–769, 1997. View at Google Scholar
  54. M. Tahir, M. U. Rehman, A. Lateef et al., “Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model,” Toxicology Letters, vol. 220, no. 3, pp. 205–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Tanaka, H. Makita, K. Kawabata et al., “Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin,” Carcinogenesis, vol. 18, no. 5, pp. 957–965, 1997. View at Google Scholar
  56. M. Rajasekar, K. Suresh, and K. Sivakumar, “Diosmin induce apoptosis through modulation of STAT-3 signaling in 7,12 dimethylbenz(a)anthracene induced harmster buccal pouch carcinogenesis,” Biomedicine & Pharmacotherapy, vol. 83, pp. 1064–1070, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. H. H. Arab, S. A. Salama, H. A. Omar, E. S. Arafa, and I. A. Maghrabi, “Diosmin protects against ethanol-induced gastric injury in rats: novel anti-ulcer actions,” PloS One, vol. 10, no. 3, article e0122417, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Cetinkaya, E. Bulbuloglu, E. B. Kurutas, and B. Kantarceken, “N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats,” Medical Science Monitor, vol. 12, no. 8, pp. BR274–BR278, 2006. View at Google Scholar
  59. Y. Cağlar, H. Özgür, I. Matur et al., “Ultrastructural evaluation of the effect of N-acetylcysteine on methotrexate nephrotoxicity in rats,” Histology and Histopathology, vol. 28, no. 7, pp. 865–874, 2013. View at Publisher · View at Google Scholar
  60. M. Bozkurt, M. N. Bodakci, G. Turkcu et al., “Protective effects of carvacrol against methotrexate-induced liver toxicity in rats,” Acta Chirurgica Belgica, vol. 114, no. 6, pp. 404–409, 2014. View at Google Scholar
  61. M. Bozkurt, S. Em, P. Oktayoglu et al., “Carvacrol prevents methotrexate-induced renal oxidative injury and renal damage in rats,” Clinical & Investigative Medicine, vol. 37, pp. 19–25, 2014. View at Google Scholar
  62. M. A. Morsy, S. A. Ibrahim, E. F. Amin, M. Y. Kamel, R. A. Rifaai, and M. K. Hassan, “Curcumin ameliorates methotrexate-induced nephrotoxicity in rats,” Advances in Pharmacological Sciences, vol. 2013, Article ID 387071, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. D. O. Dabak and N. Kocaman, “Effects of silymarin on methotrexate-induced nephrotoxicity in rats,” Renal Failure, vol. 37, no. 4, pp. 734–739, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Perwaiz Iqbal, F. Sultana, N. Mehboobali, and S. Pervez, “Folinic acid protects against suppression of growth by methotrexate in mice,” Biopharmaceutics & Drug Disposition, vol. 22, no. 4, pp. 169–178, 2001. View at Google Scholar